Dengue Seroprevalence Study in Blood Donors in the French West Indies

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

817 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-05-31

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dengue is an infectious disease most prevalent in the world. This disease is endemic in the Caribbean, with an increase in seasonal rains. Several outbreaks have been observed in recent years, in 2001, 2005 and 2007, during which further particularly virulent serotypes have emerged. The clinical expression of dengue fever is variable, ranging from no symptoms to a classical form with fever, and even of severe or lethal bleeding. With the possible existence of silent forms of the disease, there are no data identifying the current level of protection of the population in Martinique / Guadeloupe.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean

NCT04839757

Dengue Vaccination Seroprevalence +1 more

RECRUITING

Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children

NCT01477671

Dengue Dengue Fever Dengue Hemorrhagic Fever

COMPLETED

This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia

NCT02766088

Dengue Dengue Vaccines

TERMINATED NA

An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil

NCT01751139

Dengue

TERMINATED NA

Factors Associated With Hospitalization for Dengue and Dengue Severity: Hospital-based Cohort Study on Reunion Island

NCT05607472

Dengue Fever With Warning Signs

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Principal objective:

To estimate the prevalence of the specific antibodies of the dengue (IgG) in blood donors in the French West Indies.
2. Secondary objective:

To specify the serotypic specificity of the anti-dengue antibodies detected during the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Donors Dengue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biological sample collection

Blood (serum) sample collection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eligible for blood donation following the French legislation,
* Resident in Martinique /Guadeloupe for at least one year
* Consent signed

Exclusion Criteria

* Not Eligible for blood donation following the French legislation,
* Not Resident in Martinique / Guadeloupe for at least one year
* Consent not signed

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes